Innate Pharma SA (NASDAQ:IPHA)

7.60
Delayed Data
As of Jan 22
 +0.09 / +1.20%
Today’s Change
5.61
Today|||52-Week Range
8.24
+18.01%
Year-to-Date
No recent news for Innate Pharma SA.

Today’s Trading

Previous close7.51
Today’s open7.71
Day’s range7.50 - 7.71
Volume14,246
Average volume (3 months)45,975
Market cap$568.2M
Data as of 1:32pm ET, 01/22/2020

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-309.59%
Earnings growth (next 5 years)-22.50%
Revenue growth (last year)+156.08%
P/E ratio13.4
Price/Sales--
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
KURAKura Oncology Inc-0.04-0.32%
MGNXMacroGenics Inc-0.37-3.06%
ASMBAssembly Biosciences...-0.18-1.03%
NLTXNeoleukin Therapeuti...+0.27+2.43%
Data as of 4:00pm ET, 01/22/2020

Financials

Next reporting dateMarch 10, 2020
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$94.3M
Annual profit (last year)$3.6M
Net profit margin3.82%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts